Use of tumor budding with K-RAS gene analysis to identify potentially responsive metastatic colorectal cancer patients treated with anti-EGFR therapies.

e14042 Background: Tumor budding in colorectal cancer is recognized by the International Union against Cancer as a highly relevant, additional prognostic factor and defined as single cells or clust...